###begin article-title 0
###xml 0 14 <span type="species:ncbi:39054">Enterovirus 71</span>
Enterovirus 71 3C Protease Cleaves a Novel Target CstF-64 and Inhibits Cellular Polyadenylation
###end article-title 0
###begin p 1
Conceived and designed the experiments: KFW SRS. Performed the experiments: KFW MLL CTH. Analyzed the data: KFW SRS. Wrote the paper: KFW SRS.
###end p 1
###begin p 2
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 667 675 667 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 681 684 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 709 712 709 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 790 793 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 861 864 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1141 1149 1141 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1239 1242 1239 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1399 1402 1399 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1474 1482 1474 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 195 209 <span type="species:ncbi:39054">enterovirus 71</span>
###xml 211 215 <span type="species:ncbi:39054">EV71</span>
###xml 509 513 <span type="species:ncbi:39054">EV71</span>
###xml 774 778 <span type="species:ncbi:39054">EV71</span>
###xml 1117 1121 <span type="species:ncbi:39054">EV71</span>
Identification of novel cellular proteins as substrates to viral proteases would provide a new insight into the mechanism of cell-virus interplay. Eight nuclear proteins as potential targets for enterovirus 71 (EV71) 3C protease (3Cpro) cleavages were identified by 2D electrophoresis and MALDI-TOF analysis. Of these proteins, CstF-64, which is a critical factor for 3' pre-mRNA processing in a cell nucleus, was selected for further study. A time-course study to monitor the expression levels of CstF-64 in EV71-infected cells also revealed that the reduction of CstF-64 during virus infection was correlated with the production of viral 3Cpro. CstF-64 was cleaved in vitro by 3Cpro but neither by mutant 3Cpro (in which the catalytic site was inactivated) nor by another EV71 protease 2Apro. Serial mutagenesis was performed in CstF-64, revealing that the 3Cpro cleavage sites are located at position 251 in the N-terminal P/G-rich domain and at multiple positions close to the C-terminus of CstF-64 (around position 500). An accumulation of unprocessed pre-mRNA and the depression of mature mRNA were observed in EV71-infected cells. An in vitro assay revealed the inhibition of the 3'-end pre-mRNA processing and polyadenylation in 3Cpro-treated nuclear extract, and this impairment was rescued by adding purified recombinant CstF-64 protein. In summing up the above results, we suggest that 3Cpro cleavage inactivates CstF-64 and impairs the host cell polyadenylation in vitro, as well as in virus-infected cells. This finding is, to our knowledge, the first to demonstrate that a picornavirus protein affects the polyadenylation of host mRNA.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 776 779 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 876 879 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1060 1063 1060 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 344 358 <span type="species:ncbi:39054">enterovirus 71</span>
###xml 408 422 <span type="species:ncbi:39054">Enterovirus 71</span>
###xml 514 524 <span type="species:ncbi:138953">poliovirus</span>
###xml 599 613 <span type="species:ncbi:39054">enterovirus 71</span>
###xml 731 735 <span type="species:ncbi:39054">EV71</span>
Many viruses contain specific proteases that are essential for processing their own viral proteins. For an efficient replication within their hosts, on the other hand, viruses also utilize these proteases to cleave a number of key host proteins and hijack cellular machineries. In this study, host proteins are identified as the substrates for enterovirus 71 viral protease by adopting a proteomic strategy. Enterovirus 71 infection is highly associated with neurological complication and mortality in an era when poliovirus has been controlled by vaccination. Investigating the host substrates for enterovirus 71 protease may shed light on the viral-host interaction, ultimately providing further insight into the pathogenesis of EV71 infection. We found that 3C protease (3Cpro) cleaved CstF-64, the latter a cleavage stimulation factor in host polyadenylation machinery. 3Cpro is known to enter host nucleus, whereas the replication of the virus occurs in cytoplasm. While its role in nucleus has been thought to inhibit host transcription, we found that 3Cpro may inhibit host-cell gene expression at host 3'-end pre-mRNA processing and polyadenylation steps. Consequently, less polyadenylated host mRNA is synthesized and more cellular resources, such as the translation factors, would be available for viral RNA expression.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 47 61 47 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Picornaviridae</italic>
###xml 673 676 673 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Ho1">[1]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-AbuBakar2">[10]</xref>
###xml 0 14 <span type="species:ncbi:39054">Enterovirus 71</span>
###xml 16 20 <span type="species:ncbi:39054">EV71</span>
###xml 72 82 <span type="species:ncbi:138953">poliovirus</span>
###xml 97 101 <span type="species:ncbi:39054">EV71</span>
###xml 226 230 <span type="species:ncbi:39054">EV71</span>
###xml 324 328 <span type="species:ncbi:39054">EV71</span>
Enterovirus 71 (EV71) belongs to the family of Picornaviridae, to which poliovirus also belongs. EV71 infection usually causes childhood herpagina or exanthema, which is also called hand, foot, and mouth disease (HFMD). Acute EV71 infection may also cause a severe polio-like neurological disease and significant mortality. EV71-related neurological complications include aseptic meningitis, brainstem and/or cerebellar encephalitis, acute flaccid paralysis (AFP), myocarditis, and rapid fatal pulmonary edema and hemorrhage, which have been observed during outbreaks in Taiwan, mainland China, Malaysia, Brunei, Singapore, western Australia, the United States, and Europe [1]-[10].
###end p 6
###begin p 7
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Etchison1">[11]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Rose1">[12]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark1">[13]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark2">[14]</xref>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Hammerle1">[15]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Li1">[20]</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Kitamura1">[21]</xref>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Amineva1">[22]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Sharma1">[23]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark1">[13]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark2">[14]</xref>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Yalamanchili1">[24]</xref>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Weidman1">[27]</xref>
###xml 1007 1010 1007 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1197 1200 1197 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 362 372 <span type="species:ncbi:138953">poliovirus</span>
###xml 377 381 <span type="species:ncbi:39054">EV71</span>
###xml 1000 1004 <span type="species:ncbi:39054">EV71</span>
###xml 1108 1112 <span type="species:ncbi:39054">EV71</span>
###xml 1190 1194 <span type="species:ncbi:39054">EV71</span>
Numerous host machineries are affected by picornaviral infection, including host cap-dependent translation [11],[12] and transcription [13],[14]. Viral proteases are responsible for inhibitory effects. Picornaviruses typically encode two viral proteases, 2Apro and 3Cpro, which are important for viral polypeptide processing. The major catalytic sites of type I poliovirus and EV71 3Cpro are His40, Glu71, and Cys147 [15]-[20]. In general, enterovirus 3C proteinases cleave at Gln/Gly scissile pairs [21]. Picornaviral 3Cpro can enter nuclei through its precursor 3CD' or 3CD, which contains a nuclear localization sequence (NLS) [22],[23], and can cleave some cellular transcriptional factors or regulators, such as TATA-box binding protein, p53, Histone H3 and transcription factor IIIC [13], [14], [24]-[27], offering insight into the effects of these factors or regulators on the transcriptional machinery of the host. Therefore, the identification of other cellular proteins that are cleaved by EV71 3Cpro in nuclei is of interest, as it may help us to understand unknown viral-host interactions during EV71 infection. In this work, a novel nuclear factor, CstF-64, that is cleaved by EV71 3Cpro, is identified.
###end p 7
###begin p 8
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Ford1">[28]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Wickens1">[31]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Silvestri1">[32]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Kusov1">[33]</xref>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-DorschHasler1">[34]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Zhao1">[35]</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Colgan1">[36]</xref>
###xml 1302 1306 1302 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-MacDonald1">[37]</xref>
###xml 1308 1316 1308 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1321 1328 1321 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1408 1412 1408 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki1">[38]</xref>
###xml 1413 1417 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Zhu1">[39]</xref>
###xml 284 294 <span type="species:ncbi:138953">poliovirus</span>
Poly(A) tails are important for both cellular mRNA and picornaviral mRNA. The poly(A) tail in eukaryotic cells is suggested to confer mRNA stability, promote the translational efficiency of mRNA, and the transport mRNA from the nucleus to the cytoplasm [28]-[31]. The poly(A) tail of poliovirus is critical to viral replication [32],[33]. However, poly(A) for picornaviruses is obtained differently from that for host cells. The poly(A) tail of picornaviruses is encoded by the genome, copied into a 5' poly(U) tract in the negative sense form, then back into a poly(A) tail during the virus RNA replication cycle [34]. Polyadenylation of most eukaryotes involves a series of steps. Prior to poly(A) synthesis, a polyadenylation signal located at the 3' end of precursor mRNA (pre-mRNA) must be recognized by multiple factors such as cleavage factors I and II (CF I and II), cleavage/polyadenylation specificity factor (CPSF) and cleavage stimulation factor (CstF) complex, which causes endonucleolytical cleavage at the site of polyadenylation [35],[36]. One of these factors, cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CstF-64) is responsible for recognizing the second polyadenylation sequence element, a G/U-rich motif which is down-stream of the polyadenylation sites on pre-mRNA [37]. In vitro and in vivo blockage of CstF-64 impairs the 3'-end pre-mRNA processing and polyadenylation [38],[39].
###end p 8
###begin p 9
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 609 617 609 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 667 670 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 78 82 <span type="species:ncbi:39054">EV71</span>
###xml 319 323 <span type="species:ncbi:39054">EV71</span>
###xml 390 394 <span type="species:ncbi:39054">EV71</span>
###xml 428 432 <span type="species:ncbi:39054">EV71</span>
###xml 590 594 <span type="species:ncbi:39054">EV71</span>
This work identified eight cellular nuclear proteins as potential targets for EV71 3Cpro cleavage by two-dimensional (2D) electrophoresis and MALDI-TOF analysis. CstF-64, the target selected from these eight proteins, is further examined. CstF-64 in the nuclear extract was verified by western blot to be degraded upon EV71 3Cpro treatment. The reduction and cleavage pattern of CstF-64 in EV71-infected cells were studied. The EV71 3Cpro cleavage sites in CstF-64 were also mapped by performing an in vitro cleavage assay. The 3'-end pre-mRNA processing in host cells was monitored during EV71 infection. An in vitro assay was also conducted to test the effect of 3Cpro on the cellular 3'-end pre-mRNA processing and polyadenylation. The findings herein are the first to demonstrate that a picornaviral protease interferes with host gene expression at the machinery of polyadenylation.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 39 43 <span type="species:ncbi:39054">EV71</span>
Identification of CstF-64 as Potential EV71 3Cpro Substrate in Nuclear Extract
###end title 11
###begin p 12
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Amineva1">[22]</xref>
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Sharma1">[23]</xref>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 324 327 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 340 343 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 374 376 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Shih1">[19]</xref>
###xml 540 543 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 573 580 573 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g001">Fig. 1A</xref>
###xml 616 619 616 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 632 635 632 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 890 897 884 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g001">Fig. 1B</xref>
###xml 995 998 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1072 1075 1066 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1395 1402 1389 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000593-t001">Table 1</xref>
###xml 1491 1494 1485 1488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1606 1613 1600 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g001">Fig. 1C</xref>
###xml 1626 1641 1620 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g001">Figs. 1B and 1C</xref>
###xml 1759 1762 1753 1756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 110 114 <span type="species:ncbi:39054">EV71</span>
###xml 307 311 <span type="species:ncbi:39054">EV71</span>
###xml 599 603 <span type="species:ncbi:39054">EV71</span>
###xml 1752 1756 <span type="species:ncbi:39054">EV71</span>
Picornavirus 3Cpro proteins can enter the nuclei of host cells [22],[23]. To identify potential substrates of EV71 3Cpro in nuclei, in vitro 3Cpro cleavage assay was conducted and the proteomic technique was utilized to identify the cellular targets. First, the catalytic activities of purified recombinant EV71 wild-type 3Cpro or mutant 3Cpro(C147S) were verified using a [35S]-labeled peptide substrate, which contains a 3Cpro cleavage site, as described elsewhere [19]. The result shows that the wild-type, but not the C147S mutant of 3Cpro cleaves the viral substrate (Fig. 1A). The recombinant EV71 wild-type 3Cpro or mutant 3Cpro were then added to nuclear extracts from SF268 cells. Following incubation for 4 hours at 37degreesC, the reactions were subjected to 2D electrophoresis. The experiments were performed six times and the results were analyzed using PDquest 7.0 (Bio-rad). Fig. 1B presents one of these six 2D electrophoresis experiments. Proteins that appeared in the mutant 3Cpro-treated reactants but in at least half of the amounts of the wild-type 3Cpro-treated reactants, based on silver staining, were regarded as potential targets. From the six pairs of gels in these 2D gel experiments, eight proteins that yielded similar results at least three times were selected. These proteins were then identified by MALDI-TOF mass spectrometry and the results were summarized in Table 1. In contrast with that of mutant 3C-treated nuclear extract, CstF-64 of the wild-type 3Cpro-treated nuclear extract was decreased to nearly undetectable levels in five individual 2D electrophoresis gel (Fig. 1C). Arrows in Figs. 1B and 1C indicate the locations of CstF-64 on 2D gels. These results suggest that CstF-64 is a potential substrate for EV71 3Cpro.
###end p 12
###begin title 13
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 28 32 <span type="species:ncbi:39054">EV71</span>
Identification of potential EV71 3Cpro substrates by 2D gels.
###end title 13
###begin p 14
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 370 373 370 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</sub>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 464 466 464 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 514 522 514 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 612 615 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 51 55 <span type="species:ncbi:39054">EV71</span>
(A) A [35S]-labeled peptide which contains part of EV71 viral polyprotein was treated with wild-type 3Cpro(WT) or mutant 3Cpro (C147S). The uncleaved peptide precursor and 3Cpro cleavage product was indicated. (B) Full scale of 2D gels for one of the six in vitro cleavage experiments; left panel shows results obtained using the mutant 3Cpro-treated nuclear extract (3Cmut); right panel shows the results obtained using wild-type 3Cpro-treated nuclear extract (3CWT). Arrows indicate location of CstF-64. (C) Six in vitro cleavage experiments on 2D gels. Arrows indicate location of CstF-64 protein on mutant 3Cpro-treated nuclear extracts gels; circles indicate the corresponding regions on wild-type 3Cpro-treated nuclear extract gels.
###end p 14
###begin title 15
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
Identification of potential 3Cpro substrates by MALDI-TOF analysis.
###end title 15
###begin p 16
Note: The sequence coverage for these proteins determined by MALDI-TOF analysis is also indicated. (Mw: molecular weight; IP: isoelectric point; a.a.: amino acids).
###end p 16
###begin title 17
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Reduction of CstF-64 in Nuclear Extracts by Addition of 3CproIn Vitro
###end title 17
###begin p 18
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Wallace1">[40]</xref>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 343 350 343 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2A</xref>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 750 753 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 874 877 874 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 938 941 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1020 1023 1020 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1025 1032 1025 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2B</xref>
###xml 1452 1455 1452 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1638 1645 1638 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2A</xref>
###xml 1839 1842 1839 1842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1996 1999 1996 1999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2024 2027 2024 2027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2153 2156 2153 2156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2219 2227 2219 2227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2276 2279 2276 2279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2385 2388 2385 2388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2434 2442 2434 2442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2444 2451 2444 2451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2C</xref>
###xml 2561 2564 2561 2564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2597 2600 2597 2600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2631 2639 2631 2639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2641 2648 2641 2648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2C</xref>
###xml 2697 2700 2697 2700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2712 2715 2712 2715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2752 2760 2752 2760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2130 2134 <span type="species:ncbi:39054">EV71</span>
###xml 2269 2273 <span type="species:ncbi:39054">EV71</span>
The reduction of CstF-64 by proteomic assay was confirmed by using an anti-CstF-64 antibody [40] to detect the level of CstF-64 in nuclear extracts from SF268 cells, which were incubated with wild-type or mutant recombinant 3Cpro. The amount of CstF-64 in SF268 nuclear extract dramatically declined following incubation with wild-type 3Cpro (Fig. 2A, lane 3), and the intact form of CstF-64 was clearly detected in mutant 3Cpro-treated nuclear extract (lane 2). One potential cleavage product of 55 kDa was also detected using CstF-64 antibody in wild-type 3Cpro-incubated nuclear extract (lanes 3, 6 and 9, indicated by *). CstF-64 levels in nuclear extracts from other cell lines, RD and HeLa cells, also declined upon incubation with wild-type 3Cpro and the cleavage pattern is similar to that in SF268 nuclear extracts. (Compare lanes 6 and 9 with results for mutant 3Cpro-treated nuclear extracts in lanes 5 and 8). The wild-type 3Cpro-induced CstF-64 reduction in nuclear extract depends on dose of recombinant 3Cpro (Fig. 2B, lanes 3-7). The intensities between the full-length CstF-64 and its 55 kDa cleavage product were not the same as expected. This discrepancy is attributed to that later in the experiments, the cleavage sites were mapped to position 251 and multiple positions close to the C-terminus (around position 500) of CstF-64. The cleavage of CstF-64 at positions around 500 produce a product of 55 kDa, which contains another 3Cpro cleavage site at its Gln251. When position 251 was mutated (Gln to Ala), the mutant CstF-64 was cleaved into a 55 kDa product with the same intensity as that of full-length CsfF-64. Fig. 2A shows a band faster than 24 KDa (lane 2, 5 and 8), which we speculate is a cleavage product from a degraded form of CstF-64. The degraded form of CstF-64 might contain the cleavage sites for 3Cpro as well as the CstF-64 antibody recognition sites. Therefore, western blot analysis detected the cleaved product from the degraded form only in mutant 3Cpro, but not in wild-type 3Cpro-treated nuclear extract because the cleavage destroyed the antibody recognition of CstF-64. The other EV71 viral protease, 2Apro was also tested to determine whether it could degrade CstF-64 in vitro. The catalytic activities of recombinant EV71 2Apro were firstly elucidated by treatment with RD cell lysate and were verified by western blot for a known 2Apro substrate, eIF-4GI, to be able to be cleaved in vitro (Fig. 2C, lane 1-3). The western blot for CstF-64 in the nuclear extracts that were treated by purified recombinant 2Apro demonstrated the inability of 2Apro to induce CstF-64 degradation in vitro (Fig. 2C, lane 4-6). These results indicate that viral 3Cpro, but not 2Apro is responsible for reducing CstF-64 in vitro.
###end p 18
###begin title 19
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
CstF-64 in 3Cpro-treated nuclear extract.
###end title 19
###begin p 20
###xml 208 211 208 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 258 261 258 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 742 745 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 843 846 823 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 859 862 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
(A) CstF-64 proteins in nuclear extracts from SF268, RD and HeLa cells were detected using anti-CstF-64 antibodies. Untreated nuclear extracts (-) were loaded as controls. The amount of CstF64 in wild-type 3Cpro treated nuclear extracts (WT) and in mutant 3Cpro-treated nuclear extracts (C147S) were showen. A cleavage product of 55 kDa was indicated (*). PCNA (proliferatory cell nuclear antigen) detection was employed as the loading control. (B) CstF-64 protein in RD nuclear extract treated with various quantities of 3Cpro - 0.5 microg , 1 microg, 2 microg , 4 microg and 5 microg (lanes 3 to 7) and in the mutant 3C-treated nuclear extract (C147S) or untreated nuclear extract (-) were shown. (C) eIF4-GI in wild-type (WT) and mutant 2Apro (C110S) treated RD cell extracts were detected using specific antibody (lanes 1-3). CstF-64 in 2Apro or mutant 2Apro-treated nuclear extract was also detected (lanes 4-6).
###end p 20
###begin title 21
###xml 24 28 <span type="species:ncbi:39054">EV71</span>
Reduction of CstF-64 in EV71-infected Cells
###end title 21
###begin p 22
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3A</xref>
###xml 646 654 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 715 718 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 777 784 777 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3A</xref>
###xml 849 856 849 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3A</xref>
###xml 1092 1099 1092 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000593.s001">Fig. S1</xref>
###xml 1425 1432 1425 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3B</xref>
###xml 1514 1521 1514 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3B</xref>
###xml 1622 1629 1622 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3A</xref>
###xml 1769 1776 1769 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3B</xref>
###xml 34 38 <span type="species:ncbi:39054">EV71</span>
###xml 95 99 <span type="species:ncbi:39054">EV71</span>
###xml 234 238 <span type="species:ncbi:39054">EV71</span>
###xml 320 324 <span type="species:ncbi:39054">EV71</span>
###xml 708 712 <span type="species:ncbi:39054">EV71</span>
###xml 1086 1090 <span type="species:ncbi:39054">EV71</span>
###xml 1249 1253 <span type="species:ncbi:39054">EV71</span>
###xml 1328 1332 <span type="species:ncbi:39054">EV71</span>
###xml 1498 1502 <span type="species:ncbi:39054">EV71</span>
###xml 1601 1605 <span type="species:ncbi:39054">EV71</span>
###xml 1918 1922 <span type="species:ncbi:39054">EV71</span>
In vitro assays demonstrated that EV71 3Cpro can cleave CstF-64; the degradation of CstF-64 in EV71-infected cells was, therefore, examined. A time-course study was conducted to monitor the levels of CstF-64 in RD cells infected with EV71 at a multiplicity of infection (m.o.i.) of 40. Total cell lysates harvested from EV71-infected RD cells at various hours post-infection (h.p.i.) were analyzed by western blot assay. Infection reduced the amount of host CstF-64 proteins from 6 to 10 hours post-infection (h.p.i.) (Fig. 3A, lanes 4, 6 and 8). One potential CstF-64 cleavage product of 55 kDa (indicated by *) which resembles that obtained by in vitro cleavage, began to be detected at 6 h.p.i. (lane 4). EV71 3Cpro in the same infected cells was also observed at 6 h.p.i. (Fig. 3A, lane 4), and its level increased markedly from 8 to 10 h.p.i. (Fig. 3A, lane 6-8), in a manner that is related to the degradation times of CstF-64 in infected cells. The reduction of CstF-64 and the appearance of 55-kDa product were also observed in cells infected with a lower titer (m.o.i of 1) of EV71 (Fig. S1), but with a 2 hour delay. To detect other cleavage products from CstF-64, a CstF-64 that was fused with FLAG at its N-terminal was overexpressed in EV71-infected cells and detected using FLAG antibody at 6 and 8 h.p.i.. During EV71 infection, FLAG-CstF-64 was cleaved into products of size 55 kDa and 30 kDa (CP1 and CP2 in Fig. 3B). The 55 kDa products from FLAG-CstF-64 reduced at late point of EV71 infection (Fig. 3B, CP1, compare lanes 2 and 4), similar to the result from endogenous CstF-64 in EV71-infected cells (Fig. 3A, the bands marked as * in lane 4 and 6). On the other hand, another cleavage product of about 30 kDa was increased during virus infection (Fig. 3B, CP2 compare lanes 2 and 4). The 55 kDa intermediate cleavage products suggest that CstF-64 may be cleaved at more than one cleavage site in EV71-infected cells.
###end p 22
###begin title 23
###xml 11 15 <span type="species:ncbi:39054">EV71</span>
CstF-64 in EV71-infected cells.
###end title 23
###begin p 24
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 824 827 821 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 43 47 <span type="species:ncbi:39054">EV71</span>
###xml 452 456 <span type="species:ncbi:39054">EV71</span>
###xml 757 761 <span type="species:ncbi:39054">EV71</span>
###xml 1057 1061 <span type="species:ncbi:39054">EV71</span>
(A) After RD cells have been infected with EV71 (m.o.i. = 40), 3Cpro and CstF-64 protein in total cellular proteins of infected RD cells (+) or mock infected cells (-) were detected at various hours post-infection (h.p.i.) using specific antibodies. A potential cleavage product of CstF-64 was also indicated (*). The detection of beta-actin was used as a loading control (B) RD cells with transient FLAG-CstF-64 overexpression were also infected with EV71 at an m.o.i. of 40 and the total cellular proteins from mock infected (-) and infected cells (+) were harvested at 6 and 8 h.p.i.. FLAG-CstF-64 was detected using FLAG-specific antibody. The other cleaved FLAG-peptides were indicated as CP1 and CP2 (C) Cytoplasmic (C) and nuclear (N) fractions from EV71-infected RD cells at 8 h.p.i. were extracted and CstF-64 or 3Cpro in each of the fractions were detected using specific antibodies. Detections of beta-actin and histon deacetylase (HDAC) were used as cytoplasmic and nucleus protein controls. (D) The locations of CstF-64 in uninfected (Mock) or EV71-infected cells at 2, 4, 6, 8 and 10 h.p.i. were detected using specific antibody. The detection of viral 2B protein was applied as an infection-positive marker. The nuclei of cells were stained using Hoechst dye.
###end p 24
###begin p 25
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Gustin1">[41]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Lin1">[43]</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3D</xref>
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000593.s002">Fig. S2</xref>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 776 779 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 845 852 845 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3C</xref>
###xml 893 896 893 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-FernandezTomas1">[44]</xref>
###xml 1067 1074 1067 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3C</xref>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki1">[38]</xref>
###xml 1179 1186 1179 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3D</xref>
###xml 1272 1279 1272 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3C</xref>
###xml 201 205 <span type="species:ncbi:39054">EV71</span>
###xml 616 620 <span type="species:ncbi:39054">EV71</span>
###xml 660 664 <span type="species:ncbi:39054">EV71</span>
###xml 769 773 <span type="species:ncbi:39054">EV71</span>
###xml 886 890 <span type="species:ncbi:39054">EV71</span>
Picornavirus infection can relocalize numerous nuclear proteins to the cytoplasm [41]-[43]. To determine whether CstF-64 also undergoes changes in sub-cellular localization, the location of CstF-64 in EV71-infected was monitored by immunohistostaining using a confocal microscope. The result demonstrated that most CstF-64 remains in the nucleus of the infected cells at 6 to 10 h.p.i. (Fig. 3D), whereas the other nuclear factor, heterogeneous nuclear ribonucleoprotein K (hnRNP K), is redistributed to the cytoplasm (Fig. S2). Our 3C Ab was unable to be used in confocal experiment; therefore to determine whether EV71 3Cpro was also present in the nucleus, EV71-infected cells were fractionated into cytoplasmic and nucleus fractions. Western blot demonstrated that EV71 3Cpro is equally distributed across cytoplasmic and nuclear fractions (Fig. 3C, lanes 2 and 4), indicating that EV71 3Cpro can enter into a host nucleus during virus infection, as can other picornaviruses [44]. CstF-64 was detected to be localized primarily in the nuclei of uninfected cells (Fig. 3C, lane 3 compared to lane 1), consistent with previous findings [38] and confocal data presented herein (Fig. 3D). However, CstF-64 in both nuclei and cytoplasm were cleaved during virus infection (Fig. 3C, lanes 2 and 4).
###end p 25
###begin title 26
###xml 2 5 2 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
3Cpro Cleaves CstF-64 Protein In Vitro
###end title 26
###begin p 27
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 159 166 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2A</xref>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
The results presented above suggest that the CstF-64 was reduced in wild-type 3Cpro-treated nuclear extracts but not in mutant 3Cpro-treated nuclear extracts (Fig. 2A). Therefore, 3Cpro is reasonably hypothesized to cause the reduction of CstF-64 by proteolytic cleavage.
###end p 27
###begin p 28
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 150 158 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 229 231 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4A</xref>
###xml 593 596 593 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 625 627 625 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 752 759 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4B</xref>
###xml 776 784 776 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 798 801 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 818 825 818 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4B</xref>
###xml 889 896 889 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4A</xref>
Details of the cleavage were elucidated using a [35S]-labeled CstF-64 generated by in vitro transcription and translation (TNT) as a substrate in the in vitro 3Cpro cleavage assay. After it had incubated with recombinant 3Cpro, [35S]-labeled CstF-64 can be cleaved into fragments of approximately 25 and 30 kDa (Fig. 4A, lane 3). Since the size of these two peptides do not correlate with the full-length size of CstF-64 (64 kDa compared to 25 kDa+30 kDa = 55 kDa), at least one cleavage product smaller than 10 kDa that could not be detected in PAGEs was expected to exist. To identify the 3Cpro cleavage sites on CstF-64, [35S]-labeled CstF-64 and a series of truncated CstF-64 peptides that were designed according to functional domains of CstF-64 (Fig. 4B) were generated in vitro by TNT for 3Cpro cleavage assay. Fig. 4B summarizes the size of these cleavage products, estimated from Fig. 4A. The peptides 221-409 and 410-557 were both cleaved suggesting that CstF-64 included at least two cleavage sites. The 20 kDa peptide 410-557 was cleaved into the product of 10 kDa, suggesting that a cleavage site was located close to the C-terminus of CstF-64. Peptide 1-220 (25 kDa) was not cleaved but peptides 221-409 and 110-409 were both cleaved into a product of about 17 kDa, suggesting that one cleavage site can produce a product of 30 kDa from the N-terminal of CstF-64. The cleavage of peptide 221-469 supported this conclusion. In summary, these cleavage results suggest the existence at least two potential cleavage sites around the amino acid position 250 and 500 of the CstF-64 protein.
###end p 28
###begin title 29
###xml 2 5 2 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
3Cpro cleaves recombinant CstF-64 protein in vitro.
###end title 29
###begin p 30
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 145 147 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 500 503 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 684 687 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 805 807 805 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 915 918 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
(A) To locate the 3Cpro cleavage sites on CstF-64, [35S]-labeled CstF-64 and numerous partial CstF-64 peptides which contain 1st-220th, 221st-409th, 410th-577th, 110th-409th, 221st-469th amino acids of CstF-64 were generated based on the functional domains of CstF-64, including RNA recognition motif (RRM), hinge domain, Pro/Gly rich domains (P/G), MEARA sequence, and C-terminal domain (C-ter) as displayed in (B). These untreated [35S]-labeled peptides (-) and those were treated with wild-type 3Cpro (WT) and mutant 3Cpro (C147S) were analyzed in SDS-PAGE. The mass of cleavage products and suspected cleavage sites (arrows) are summarized in (B), indicating that the predicted 3Cpro cleavage sites of full-length CstF-64 are around the amino acid positions 250 and 500 of CstF-64. (C) The untreated [35S]-labeled CstF-64 proteins (-) and those incubated with catalytic mutant 3C protein (C147S) or wild-type 3Cpro (WT) with various incubation times (15, 30, 60, 90, 120, 150 and 180 minutes) were analyzed in SDS-PAGE. The cleavage products of 55 kDa (p55), 35 kDa (p35), 30 kDa (p30) and 25 kDa (p25) were also indicated.
###end p 30
###begin p 31
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 52 60 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 123 130 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4A</xref>
###xml 204 212 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 235 237 231 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 282 285 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 300 307 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4C</xref>
###xml 961 964 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 994 1001 990 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000593.s003">Fig. S3</xref>
###xml 1061 1068 1057 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4C</xref>
A high amount of 3Cpro (5 microg) was used in above in vitro cleavage assay, and the incubation time was fixed at 3 hours (Fig. 4A). An attempt was made to detect the cleavage intermediates by performing in vitro kinetics analysis of [35S]-labeled CstF-64 cleavage by recombinant 3Cpro. According to Fig. 4C, three cleavage products began to appear at 15 min. A 55 kDa product resulted from cleavage at positions around 500, while two products of 30 (front) and 35 (rear) kDa both resulted from cleavage at position around 250. A new 25 kDa product began to appear at 60 min, in addition to the three previously detected products. This 25 kDa segment is attributed to the further cleaving of either the aforementioned 35 (rear) kDa product at positions around 500 or the 55 kDa product at position around 250. As the incubation time exceeded 2 hours, only the 25 and 30 kDa products dominated and became the final cleavage products. Various concentrations of 3Cpro were added to the reactions (Fig. S3), and similar cleavage products were observed, as shown in Fig. 4C.
###end p 31
###begin title 32
###xml 10 13 10 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Mapping 3Cpro Cleavage Sites on CstF-64 In Vitro
###end title 32
###begin p 33
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Kitamura1">[21]</xref>
###xml 251 254 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5A</xref>
###xml 540 543 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 598 600 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 946 949 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 960 967 948 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5B</xref>
###xml 982 985 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1092 1099 1080 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5C</xref>
###xml 1226 1233 1214 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5B</xref>
###xml 1298 1301 1286 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1340 1348 1328 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1736 1739 1724 1727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1751 1758 1739 1746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5C</xref>
###xml 1864 1867 1852 1855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1879 1886 1867 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5D</xref>
###xml 2282 2289 2270 2277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000593.s004">Fig. S4</xref>
###xml 2355 2358 2343 2346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2467 2470 2455 2458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2722 2725 2710 2713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 2715 2719 <span type="species:ncbi:39054">EV71</span>
Picornavirus 3Cpro generally cleaves peptides at the Gln/Gly junction [21]. Based on the cleavage results presented above, an analysis of the amino acid sequence of CstF-64 was conducted, revealing that numerous Gln/Gly junctions may have potential 3Cpro cleavage sites on CstF-64 (Fig. 5A). They are Gln251, corresponding to the predicted cleavage site in the region of amino acid 250, and residues Gln483, 496, 505, 510, 515 at around the amino acid position 500 on CstF-64. To determine which Gln/Gly junction on CstF-64 is the actual 3Cpro cleavage site, an attempt was made to produce mutant [35S]-labeled CstF-64 at putative Gln/X cleavage sites. Since two cleavage sites around the amino acids positions 250 and 500 of CstF-64 were estimated, cleavage at position around 250 is expected to produce a product of approximately55 KDa. However, as is predicted, a CstF-64 in which both 250 and 500 sites are mutated would be fully withstand 3Cpro cleavage (Fig. 5B). Following 3Cpro-treatment, the CstF-64 with the mutation of Gln251 into Ala (Q251A) yielded a cleavage product of 55 KDa (Fig. 5C, lanes 1-3), which is consistent with the predicted product when the cleavage site around amino acid position 250 is blocked (Fig. 5B). This result suggests that the Gln251 of CstF-64 is the only 3Cpro cleavage site around the position 250 in vitro. To identify the other cleavage sites around the amino acid position 500 of CstF-64, CstF-64(Q251A) was further mutated at the Gln483, 496, 505, 510 and 515 amino acids into Ala (Q483A, Q496A, Q505A, Q510A and Q515A, respectively). The results indicate that CstF-64(Q251A) peptides with single mutations on these potential cleavage sites are not completely resistant to wild-type (WT) 3Cpro treatment (Fig. 5C, lanes 4-18). A mutant CstF-64(Q251A) with Q483A, Q496A, Q505A, Q510A, and Q515A is fully resistant to 3Cpro treatment (Fig. 5D, lanes 4-6), suggesting that the existence of multiple cleavage sites around the amino acid position 500 of CstF-64 in the five residues, Gln483, 496, 505, 510 and 515. Moreover, the cleavage pattern was examined in a mutant CstF-64 (CstF-64-5 m), in which all Gln/Gly sites around position 500 were mutated. This observation indicates that CstF-64-5 m was cleaved into two detectable products (Fig. S4): a) 30 kDa product, i.e. the N-terminal part of CstF-64 after 3Cpro cleaves it at Gln/Gly of position 251 and b) the 35 KDa product, i.e. the C-terminal part of CstF-64 when 3Cpro cleaves it at Gln/Gly of position 251, but not at Gln/Gly sites near position 500. Taken together, above results demonstrate that Gln to Ala mutations at position 251 and multiple sites around position 500 let CstF-64 become fully resistant to EV71 3Cpro cleavage.
###end p 33
###begin title 34
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Multiple 3Cpro cleavage sites around the amino acid positions 250 and 500 of CstF-64 in vitro.
###end title 34
###begin p 35
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 380 383 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 401 403 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 533 536 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 554 557 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 575 577 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
(A) Gln/Gly (Q/G) junctions located around amino acid positions 250 and 500 of CstF-64, including Gln251, 483, 496, 505, 510 and 515. (B) Predicted size of 3Cpro cleavage products on CstF-64 with mutations at the cleavage site close to amino acid position 250 of CstF-64 (250) or at both the cleavage sites at positions 250 and 500 (250+500). (C) Wild-type 3Cpro (WT) or mutant 3Cpro (C147S)-treated [35S]-labeled CstF-64(Q251A) with a single Gln483, 496, 505, 510 or 515 (Q483A, Q496A, Q505A, Q510A, Q515A) mutation (D) Wild-type 3Cpro (WT) or mutant 3Cpro (C147S)-treated [35S]-labeled CstF-64(Q251A) or CstF-64(Q251A) with multiple mutations of Q483A, Q496A, Q505A, Q510A and Q515A.
###end p 35
###begin title 36
###xml 48 52 <span type="species:ncbi:39054">EV71</span>
Cellular 3' Pre-mRNA Processing Was Impaired in EV71-infected Cells
###end title 36
###begin p 37
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Zhao1">[35]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki1">[38]</xref>
###xml 780 787 780 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6A</xref>
###xml 1133 1140 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6A</xref>
###xml 1244 1251 1244 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6B</xref>
###xml 170 174 <span type="species:ncbi:39054">EV71</span>
###xml 268 272 <span type="species:ncbi:39054">EV71</span>
###xml 343 347 <span type="species:ncbi:39054">EV71</span>
###xml 455 459 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 759 763 <span type="species:ncbi:39054">EV71</span>
###xml 1029 1033 <span type="species:ncbi:39054">EV71</span>
###xml 1413 1417 <span type="species:ncbi:39054">EV71</span>
CstF-64 is an important factor for host 3' pre-mRNA processing and RNA polyadenylation [35],[38]. Results presented above demonstrate the reduction of CstF-64 protein in EV71-infected cells; therefore, whether the machinery of host cell polyadenylation is affected by EV71 infection was further examined. Initially, the pre-mRNA processing in EV71-infected cells was assessed using an artificial exogenous expressed GFP RNA. The pEGFP plasmid contained a SV40 polyadenylation signal sequence, which was commonly used in the study of cellular mRNA processing and polyadenylation. Primers that target GFP pre-mRNA and an oligo-dT primer that targets GFP poly(A) mRNA were used in RT-PCR for detecting RNA species (pre-mRNA and mature mRNA with poly(A) tail) in EV71-infected cells (Fig. 6A). A set of primers that target the GFP coding region, which can theoretically detect both pre-mRNA and mRNA with a poly(A) tail, were also utilized as controls to demonstrate the total amount of GFP RNA in cells. RD cells were infected with EV71 after they were transfected with eGFP plasmid. Additionally, by adopting those primers designed in Fig. 6A, RT-PCR analysis was performed for semi-quantifying different GFP RNA species in these infected cells (Fig. 6B). After they were calibrated to the total amount of GFP, the results revealed the accumulation of unprocessed pre-mRNA and a reduction in polyadenylated mRNA in EV71-infected cells.
###end p 37
###begin title 38
###xml 29 33 <span type="species:ncbi:39054">EV71</span>
Pre-mRNA and poly(A)-mRNA in EV71-infected cells.
###end title 38
###begin p 39
###xml 243 247 <span type="species:ncbi:39054">EV71</span>
###xml 423 427 <span type="species:ncbi:39054">EV71</span>
###xml 647 651 <span type="species:ncbi:39054">EV71</span>
###xml 668 672 <span type="species:ncbi:39054">EV71</span>
###xml 789 793 <span type="species:ncbi:39054">EV71</span>
(A) Primers that target the region downstream of the polyadenylation site and poly(A) tail sequence, were designed to detect pre-mRNA and poly(A) mRNA of GFP. (B) After plasmid pEGFP was transfected into the RD cells, cells were infected with EV71 and total RNA of infected cells was harvested at 6 and 8 h.p.i. for RT-PCR assay. RT-PCR results demonstrate the accumulation of pre-mRNA and the reduction of poly(A)-mRNA in EV71-infected cells at six and eight hours post-infection (h.p.i.). Following calibration to the total amount of GFP RNA, the fold changes from the amount of pre-mRNA and poly(A)-RNA in mock-infected cells (Mock) to that of EV71-infected cells (EV71) were calculated. (C) The endogenous pre-mRNA and poly(A)-mRNA of Interleukin-10 receptor beta (IL-10RB) in mock or EV71 infected cells at 8 h.p.i. were estimated based on real-time PCR. The relative amounts of pre-mRNA and poly(A)-mRNA were normalized by total IL-10RB RNA.
###end p 39
###begin p 40
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Shih2">[45]</xref>
###xml 666 673 666 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6C</xref>
###xml 35 39 <span type="species:ncbi:39054">EV71</span>
###xml 244 248 <span type="species:ncbi:39054">EV71</span>
###xml 435 439 <span type="species:ncbi:39054">EV71</span>
###xml 703 707 <span type="species:ncbi:39054">EV71</span>
An attempt was made to identify if EV71 infection affected endogeneous pre-mRNA processing. Interlekin 10 receptor beta (IL-10RB) was selected as the target because, in an earlier study, the poly(A) mRNA of IL-10RB was found to be decreased in EV71-infected cells by cDNA microarray [45]. The relative amounts of IL-10RB pre-mRNA and poly(A) mRNA were monitored by real-time RT-PCR. According to those results, the IL-10RB pre-mRNA in EV71-infected cells decreased to 62.95% of that in mock-infected cells, which correlates with our previous micorarray results. Additionally, the relative amount of IL-10RB pre-mRNA increased to 156% of that in mock-infected cells (Fig. 6C). Above results suggest that EV71 infection impairs the CstF-64-related 3' pre-mRNA processing mechanism.
###end p 40
###begin title 41
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
###xml 0 4 <span type="species:ncbi:39054">EV71</span>
EV71 3Cpro Inhibits Cellular 3'-end Pre-mRNA Processing and Polyadenylation In Vitro
###end title 41
###begin p 42
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki1">[38]</xref>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7A</xref>
###xml 440 447 440 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7B</xref>
###xml 488 495 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7A</xref>
###xml 512 519 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7B</xref>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7A</xref>
###xml 767 774 767 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7B</xref>
###xml 872 879 872 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7A</xref>
###xml 892 899 892 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7B</xref>
###xml 942 945 942 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 32 36 <span type="species:ncbi:39054">EV71</span>
###xml 193 197 <span type="species:ncbi:39054">EV71</span>
###xml 306 310 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 935 939 <span type="species:ncbi:39054">EV71</span>
The results herein suggest that EV71 3Cpro cleaves CstF-64, potentially inhibiting cellular pre-mRNA 3'-end formation and polyadenylation. An in vitro assay was conducted to test the effect of EV71 3Cpro on HeLa nuclear extract. The substrate employed in this assay is a capped pre-mRNA, which contains an SV40 late gene polyadenylational cleavage site [38]. A comparison with the mutant 3Cpro-treated nuclear extracts (Fig. 7A, lane 5 and Fig. 7B, lane 5) or untreated nuclear extracts (Fig. 7A, lanes 2, 3 and Fig. 7B, lanes 2, 3) shows that the cleavage of pre-mRNA and polyadenylation proceeded efficiently. However, upon wild-type 3Cpro treatment, the treated nuclear extracts lost the ability to perform pre-mRNA cleavage (Fig. 7A, lane 4) and polyadenylation (Fig. 7B, lane 4). Moreover, the impairments were rescued by adding purified recombinant CstF-64 protein (Fig. 7A, lane 6 and Fig. 7B, lane 6). The results suggest that EV71 3Cpro targeting to CstF-64 is a factor that inhibits cellular 3'-end pre-mRNA processing and polyadenylation.
###end p 42
###begin title 43
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
In vitro 3'-end pre-mRNA processing and polyadenylation of 3Cpro-treated HeLa nuclear extract.
###end title 43
###begin p 44
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
(A) Cleavage and (B) polyadenylation of pre-RNA substrates by untreated nuclear extract (-) or nuclear extracts treated with 3Cpro buffer indicated as B, mutant 3Cpro (C147S) and wild-type 3Cpro (WT) were analyzed. The recruitment of recombinant CstF-64 protein after 3Cpro treatment (WT + CstF-64) was also tested. The un-treated RNA substrate with buffer only was used as a control. The cleavaged producted (clev) and polyadenylated RNA [poly(A)] from nuclear extract-treated pre-mRNA substrate (pre) were indicated.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark1">[13]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark2">[14]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Yalamanchili1">[24]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Weidman1">[27]</xref>
###xml 266 269 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki1">[38]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-MacDonald1">[37]</xref>
###xml 593 601 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 635 638 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Figs. 4</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">5</xref>
###xml 749 757 749 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 889 892 889 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 904 910 904 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7</xref>
###xml 946 949 946 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1017 1021 1017 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki1">[38]</xref>
###xml 1064 1067 1064 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1288 1295 1288 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6B</xref>
###xml 1334 1341 1334 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6B</xref>
###xml 1623 1630 1623 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g006">Fig. 6C</xref>
###xml 259 263 <span type="species:ncbi:39054">EV71</span>
###xml 1057 1061 <span type="species:ncbi:39054">EV71</span>
###xml 1267 1271 <span type="species:ncbi:39054">EV71</span>
###xml 1784 1788 <span type="species:ncbi:39054">EV71</span>
Picornaviral 3Cpro reportedly influences numerous cellular functions by cleaving various host proteins, which mechanism is important in shutting off cellular gene expression in transcriptional and translational levels [13], [14], [24]-[27]. Here we show that EV71 3Cpro may affect another cellular mechanism, polyadenylation, since a novel substrate, CstF-64, was identified using the proteomic approach. CstF-64 is a crucial element in cellular mRNA maturation [38]. This 64 kDa component plays a role in the CstF complex that binds to the polyadenylation signal region of pre-mRNA [37]. Our in vitro cleavage studies revealed that 3Cpro cleaves CstF-64 at amino acid position 251 and around 500 close to the C-terminal domain (Figs. 4 and 5). The in vitro data also demonstrated the blockage of pre-mRNA 3'-end processing and the polyadenylayion activities of the nuclear extract upon 3Cpro-treatment (Fig. 7). The inhibitory effect of EV-71 3Cpro resembles that of the blockage of CstF-64 by the specific antibody [38]. The results together suggest that EV71 3Cpro cleaves CstF-64 and thus inhibits the 3'-end processing of cellular pre-mRNA. Our semi-quantitative RT-PCR results support this claim because the cellular 3'-end pre-mRNA processing was inhibited in EV71-infected cells (Fig. 6B). Pre-mRNA and mature poly(A) mRNA in Fig. 6B were detected individually by using two pairs of primers. Different primers have varying sensitivities, making it difficult to achieve a quantitative correlation between the increase in precursor and decrease in polyadenylated RNA. However, a quantivitive real-time RT-PCR result (Fig. 6C) provides further evidence to demonstrate that the pre-mRNA processing or polyadenylation (either an exogenous RNA or an endogenous RNA) was impaired in EV71-infected cells.
###end p 46
###begin p 47
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000593.s005">Fig. S5</xref>
###xml 271 279 271 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 291 297 291 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7</xref>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 562 575 562 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g007">Fig. 7A and B</xref>
###xml 47 51 <span type="species:ncbi:39054">EV71</span>
###xml 166 170 <span type="species:ncbi:39054">EV71</span>
Other proteins than CstF-64 may be involved in EV71-induced inhibition of pre-mRNA processing in virus-infected cells even though the levels of poly(A) polymerase in EV71-infected cells were found to be similar to those of the mock-infected cells (Fig. S5). However, our in vitro results in Fig. 7 demonstrate that CstF-64 is the target factor that caused 3Cpro to affect 3'-end processing and polyadenylation. Adding recombinant CstF-64 can restore the function of 3C-incubated nuclear extracts on 3'-end pre-mRNA processing and polyadenylation (Lane 6 in both Fig. 7A and B).
###end p 47
###begin p 48
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Lin2">[46]</xref>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark1">[13]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark2">[14]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Falk1">[26]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Weidman1">[27]</xref>
###xml 810 816 810 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g001">Fig. 1</xref>
###xml 875 878 875 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 469 473 <span type="species:ncbi:39054">EV71</span>
Before the surge of the proteomic method, a substrate for a protease is commonly identified using western blot analysis. The proteomic approach has the advantages of the ability to identify multiple candidates simultaneously with no limitation by antibody availability. However, 2D electrophoresis and the silver staining are occasionally unable to detect proteins visible in western blot analysis [46]. This study identified eight novel proteins as the substrates for EV71 3Cpro via the proteomic approach, in which no previously known substrates for other picornaviral 3Cpro were available, such as TATA-box binding protein, p53, Histone H3 and transcription factor IIIC [13],[14],[26],[27]. This might be due to that silver staining and western blot differ in sensitivity. Moreover, the strategy adopted in Fig. 1 is set only in a single condition, i.e. the recombinant 3Cpro was incubated with nuclear extract from SF268 cells for 4 hours. More potential substrates could be identified if several interaction conditions were tested, e.g., varying in incubation time and nuclear extracts from other cell lines.
###end p 48
###begin p 49
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 133 140 133 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4B</xref>
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 243 249 243 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g002">Fig. 2</xref>
###xml 329 336 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3A</xref>
###xml 408 411 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 506 513 506 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g005">Fig. 5C</xref>
###xml 672 679 672 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Fig. 3B</xref>
###xml 954 957 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1077 1091 1065 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g003">Figs. 3A and B</xref>
###xml 1226 1234 1214 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1269 1272 1257 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1274 1281 1262 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4C</xref>
###xml 1286 1293 1274 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000593.s003">Fig. S3</xref>
###xml 1431 1439 1419 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1444 1451 1432 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1475 1478 1463 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 308 312 <span type="species:ncbi:39054">EV71</span>
###xml 656 660 <span type="species:ncbi:39054">EV71</span>
###xml 738 742 <span type="species:ncbi:39054">EV71</span>
The in vitro cleavage assay revealed that 3Cpro cleaves [35S]-labeled CstF-64 protein into detectable products of 25 kDa and 30 kDa (Fig. 4B). However, CstF-64 in 3Cpro-treated nuclear extract yielded 55 kDa products detected by western blot (Fig. 2). A product similar to that of 55 kDa was also present in EV71-infected cells (Fig. 3A). The size of the 55 kDa products above is correlated to that of the 3Cpro cleavage product when the cleavage site of the amino acid position 251 on CstF-64 is mutated (Fig. 5C). The detection of FLAG in FLAG-CstF-64 overexpressed cells revealed that the proportion of 30 kDa increased and that of 55 kDa declined upon EV71-infection (Fig. 3B). A FLAG-CstF-64 with Q251A mutation was transfected into EV71-infected cells and the results indicated the accumulation of 55 kDa products but no 30 KDa product was detected (data not shown), suggesting that the 55 kDa component was an intermediate cleavage product when 3Cpro cleaved CstF-64 at an amino acid position approximately500. The production of multiple 55 kDa bands in infected cells (Figs. 3A and B) was also observed, explaining the multiple cleavage sites around the amino acid position 500 of CstF-64. In addition, the results of in vitro kinetics of CstF-64 cleavage by 3Cpro (Fig. 4C and Fig. S3) showed a cleavage intermediate of 55 kDa. In summary, these results showed the similarity between the cleavage patterns obtained in the in vitro and in vivo assays suggests that 3Cpro may have reduced CstF-64 levels via proteolytic activity in infected cells.
###end p 49
###begin p 50
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 79 83 <span type="species:ncbi:39054">EV71</span>
Single mutation at position around 500 in CstF-64 still made it susceptible to EV71 3Cpro cleavage, while multiple mutations cause CstF-64 become resistant to the cleavage. Analytical results indicate the C-terminal of CstF-64 may contain multiple cleavage sites; otherwise, these mutations could lead to a loss of exposure of the cleavage site.
###end p 50
###begin p 51
###xml 842 845 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 956 959 956 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 63 67 <span type="species:ncbi:39054">EV71</span>
###xml 183 187 <span type="species:ncbi:39054">EV71</span>
###xml 236 240 <span type="species:ncbi:39054">EV71</span>
###xml 566 570 <span type="species:ncbi:39054">EV71</span>
###xml 1070 1074 <span type="species:ncbi:39054">EV71</span>
This study also attempted to examine whether C147S mutation in EV71 impairs the viral inhibition of cellular pre-mRNA processing and polyadenylation. However, C147S mutation rendered EV71 lethal. Alternatively, transcripts derived from EV71 infectious clones, i.e. wild-type versus C147S mutant, were transfected into cells to examine how they affect cellular pre-mRNA processing and polyadenylation. In wild-type transcript -transfected cells, CstF-64 was cleaved and cellular pre-mRNA processing was inhibited (data not shown), the same phenomenon was observed in EV71 virus-infected cells. However, in C147S mutant transcript -transfected cells, no cleavage occurred in CstF-64 and no effect on cellular pre-mRNA processing was observed, which is similar to the results in mock-infected cells. Still, no detectable viral protein (mature 3Cpro) was found. We believe that phenomenon is owing to that C147S mutation destroys the proteolytic activity of 3Cpro and inhibits viral protein processing and maturation. Therefore, we can not conclude that the C147S mutant in EV71-infected cells impairs the viral inhibition of cellular pre-mRNA processing.
###end p 51
###begin p 52
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki2">[47]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Hatton1">[50]</xref>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000593-g004">Fig. 4B</xref>
###xml 543 547 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Takagaki2">[47]</xref>
###xml 645 649 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Calvo1">[51]</xref>
###xml 775 779 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Qu1">[52]</xref>
###xml 817 820 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 853 855 849 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
CstF-64 reportedly contains at its N-terminal an RNA-binding domain and a hinge domain, which are responsible for the reorganization of RNA and its binding to CstF-77 or other factors [47]-[50]. No 3Cpro cleavage was detected in this region (1-220), suggesting that the cleaved CstF-64 maintains functions RNA binding and interaction with CstF-77 (Fig. 4B). However, the Pro/Gly-rich domains of the C-terminal region of CstF-64 form an extended alpha-helix structure and are suspected to be able to interact with several transcription factors [47], including binding of the transcription factor PC4 via the 100 amino acids of C-terminal CstF-64 [51]. One study noted that the truncation of the C-terminal domain (529-577) of CstF-64 inhibited cellular 3' pre-mRNA processing [52]. Accordingly, multiple cleavage by 3Cpro in C-terminal domain (around 500th a.a.) of CstF-64 is expected to destroy the cellular pre-mRNA processing functions of CstF-64.
###end p 52
###begin p 53
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Nemeroff1">[53]</xref>
###xml 646 650 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Noah1">[54]</xref>
###xml 817 821 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Twu1">[55]</xref>
###xml 88 105 <span type="species:ncbi:11320">influenza A virus</span>
###xml 297 301 <span type="species:ncbi:39054">EV71</span>
###xml 379 396 <span type="species:ncbi:11320">influenza A virus</span>
The RNA virus-induced inhibition of 3'-end pre-mRNA processing has been observed in the influenza A virus. NS1A of influenza A reportedly inhibits the cellular 3'-end pre-mRNA processing by interacting with CPSF-30 which is within the same machinery co-factor as CstF-64 [53]. Similar to those in EV71-infected cells, the inhibition of the cellular 3'-end pre-mRNA processing by influenza A virus causes the loss of poly(A) mRNA and the accumulation of un-poly(A) pre-mRNA. This inhibitory effect of NS1A has also been suggested to be involved in the countering of cellular antiviral responses, including virus-induced interferon beta production [54]. The capacity of NS1A to bind to CPSF-30 may also be crucial to viral replication because of high interferon-beta mRNA production in NS1A mutant virus-infected cells [55].
###end p 53
###begin p 54
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Etchison1">[11]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Clark1">[13]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Shih2">[45]</xref>
###xml 758 762 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Sarnow1">[56]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Johannes1">[58]</xref>
###xml 1066 1070 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Silvestri1">[32]</xref>
###xml 1071 1075 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Kusov1">[33]</xref>
###xml 536 540 <span type="species:ncbi:39054">EV71</span>
###xml 623 633 <span type="species:ncbi:138953">poliovirus</span>
###xml 1021 1031 <span type="species:ncbi:138953">poliovirus</span>
Picornaviruses influence host-cell gene expression by the inhibition of cellular transcription and cap-dependent mRNA translation [11]-[13]. However, several cellular genes could escape the inhibition of gene expression by picornavirus infection. Our previous cDNA microarray analysis for total cellular RNA demonstrated that the level of some RNAs, related to chemokines, protein degradation, complement proteins and proapoptosis proteins increased upon EV-71 infection [45], suggesting leakage from the inhibition of transcription by EV71. Translations of of c-myc, Bip, and eIF4G mRNA have been found to be increased in poliovirus-infected cells as the cap-dependent translation shuts down, because of the presence of internal ribosome entry sites (IRES) [56]-[58]. This work proposes a novel mechanism by which picornavirus inhibits cellular gene expression in the 3'-end pre-mRNA processing step, which would probably inhibit polyadenylation of the surviving host RNAs. It has been reported that the poly(A) tail of poliovirus is essential to viral replication [32],[33], which suggests several host poly(A)-associated factors are important for viral growth. Inhibition of cellular poly(A) RNA synthesis may provide yet an additional advantage for virus replication.
###end p 54
###begin p 55
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Silvestri1">[32]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Kusov1">[33]</xref>
###xml 127 131 <span type="species:ncbi:39054">EV71</span>
###xml 347 351 <span type="species:ncbi:39054">EV71</span>
In conclusion, a novel mechanism by which picornavirus inhibits cellular function was identified. CstF-64 was identified as an EV71 3Cpro substrate. The 3Cpro cleavage sites were mapped onto amino acid position 251 and the C-terminal region of CstF-64. The cleavage of CstF-64 impairs the cellular 3'-end pre-mRNA processing and polyadenylaytion. EV71 utilizes 3Cpro to interfere polyadenylation of host cellular RNA; however, its own poly(A) synthesis is not affected since picornaviral poly(A) tail is genetically encoded [32],[33].
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
Manipulation of cells and viruses
###end title 57
###begin p 58
###xml 233 237 <span type="species:ncbi:39054">EV71</span>
###xml 525 531 <span type="species:ncbi:9913">bovine</span>
RD and SF268 cells were maintained in DMEM that contained 10% FBS (Glibco) at 37degreesC. Cells were split in a ratio of 1:10 in fresh medium every three days. After the RD cells had grown to 80% confluence, they were washed in PBS. EV71/4643/TW viruses with a multiplicity of infection (m.o.i.) of 40 were inoculated into the cells in DMEM without FBS at room temperature for one hour to infect the cells with the virus. Following one hour of incubation, viruses and the medium were replaced by DMEM that contained 2% fetal bovine serum. Infected cells were cultured at 35degreesC.
###end p 58
###begin title 59
Plasmids and constructions
###end title 59
###begin p 60
###xml 87 90 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000593-Shih1">[19]</xref>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 497 499 497 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 623 626 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 746 749 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 756 759 756 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 1040 1048 1040 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 7 11 <span type="species:ncbi:39054">EV71</span>
###xml 26 30 <span type="species:ncbi:39054">EV71</span>
###xml 179 183 <span type="species:ncbi:39054">EV71</span>
###xml 734 737 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 926 930 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
pET-23-EV71-3C and pET-23-EV71-m3C-C147S plasmid constructs, which contain wild-type 3Cpro or mutant 3Cpro (with Cys147 replaced by Ser) cDNA in pET-23a(+) vector for recombinant EV71 3Cpro production have been constructed elsewhere [19]. For CstF-64 recombinant production, cDNA of CstF-64 was cloned from the Cst-64 coding region that contained the plasmid, pZ64-18, which was a gift from Dr. James L. Manely, and then inserted into vector pET23a(+) using EcoRV and NotI. For the production of [35S]-labeled substrates by TNT assay, full-length and partial cDNA of CstF-64 were cloned and inserted into pcDNA3.1(+) using EcoRV and NotI. For the production of FLAG-CstF-64 in transfected cells, cDNA of CstF-64 was cloned into pFLAG-CMV-2 using EcoRV and NotI. The mutant CstF-64 construct was produced using a QuikChange Site-Directed Mutagenesis Kit (Stratagene). Plasmid pG3SVL-A, which contained sequence -142 to +138 of SV40 late gene poly(A) cleavage sites was kindly provided by Dr. James L. Manely and Dr. Yoshio Takagaki, for the in vitro 3'-end pre-mRNA processing and polyadenylation assay.
###end p 60
###begin title 61
Western blot analysis
###end title 61
###begin p 62
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 384 388 <span type="species:ncbi:39054">EV71</span>
###xml 564 569 <span type="species:ncbi:10090">mouse</span>
###xml 593 599 <span type="species:ncbi:9986">rabbit</span>
PVDF membrane was blocked wih Tris-buffered saline/0.1% (vol/vol) Tween 20 that contained 5% non-fat dry milk and probed with the indicated antibody. Antibodies against CstF-64 (1:200; from Dr. Clinton C. MacDonald or 1:2000; Santa Cruz), FLAG (1:2000; SIGMA), PCNA (1:2000; Santa Cruz), HDAC (1:2000; Santa Cruz),Poly(A) polymerase (1:2000; Santa Cruz), actin (1:4000; Chemicon) and EV71 3Cpro monoclonal antibody which generated from recombinant 3Cpro protein by our lab (1:50) were used. Following washing, the membranes were incubated with HRP-conjugated anti-mouse or HRP-conjugated anti-rabbit (1:2000). HRP was detected using a Lighting Chemiluminescence reagent (Amersham Pharmacia).
###end p 62
###begin title 63
Preparation of nuclear extracts
###end title 63
###begin p 64
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 526 528 526 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,</sub>
To perform the cleavage assay in a cell-free system, SF268, HeLa or RD cells were washed in PBS and scraped out. Packed cells were re-suspended in hypotonic buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl and 0.5 mM DTT) and homogenized using a 25G needle. Homogenized cell fragments were centrifuged at 3300 g to remove cytoplasmic proteins. The pellet was washed twice in hypotonic buffer and the soluble nuclear proteins were extracted by adding buffer with a graded conc. of KCl (20 mM HEPES, 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.02 to 1.6 M KCl at pH = 7.9). After centrifuged at 25000 g, the extracted nuclear proteins in supernatant were harvested and dialyzed in buffer (20 m M HEPES , 20% glycerol, 100 mM KCl,0.2 mM EDTA and 0.5 mM DTT at pH = 7.9) and then stored at -80degreesC.
###end p 64
###begin p 65
###xml 143 147 <span type="species:ncbi:39054">EV71</span>
Commercial reagents for nuclear extraction (CMN compartment protein extraction kit; Biochain) were applied to prepare the nuclear extract from EV71-infected cells.
###end p 65
###begin p 66
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Commercial HeLa nuclear extract (Santa Cruz) was used in in vitro 3'-end pre-mRNA processing and polyadenylation assay.
###end p 66
###begin title 67
Preparation and purification of recombinant protein
###end title 67
###begin p 68
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 66 70 <span type="species:ncbi:39054">EV71</span>
###xml 82 86 <span type="species:ncbi:39054">EV71</span>
###xml 148 160 <span type="species:ncbi:511693">E. coli BL21</span>
To produce recombinant 3Cpro and CstF-64 proteins, plasmid pET-23-EV71-3C, pET-23-EV71-m3C-C147S and pET-23-CstF-64, were introduced into competent E. coli BL21 (DE3 pLysS) and protein expression was induced using 40 microM isopropyl b-D-thiogalactopyranoside. 3C-His fusion proteins were purified using a HiTrap kit (Pharmacia).
###end p 68
###begin p 69
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
To produce [35S]-labeled protein, TNT Coupled Reticulocyte Lysate Systems (Promega) was used in the in vitro transcription and translation reaction.
###end p 69
###begin title 70
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro protease cleavage assay
###end title 70
###begin p 71
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 85 88 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 311 314 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 498 501 464 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 582 584 548 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 695 698 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
In the proteomic approach to screening potential 3Cpro substrates of, 30 microg of 3Cpro was incubated with 250 microg nuclear extracts in digestion buffer (20 mM HEPES, 20% glycerol and 100 mM KCl at pH = 7.9) with total volume of 100 microl at 37degreesC for four hours. In western blot assay, 10 microg of 3Cpro was incubated with 50 microg nuclear extract under the aforementioned conditions. To cleave recombinant CstF-64, 10 microg recombinant CstF-64 proteins interacted with 10 microg of 3Cpro for four hours in the same buffer as in the earlier experiments. To cleave the [35S]-labeled substrate, 4 microl of labeled protein from one TNT assay reaction was incubated with 5 microg of 3Cpro in buffer (20 mM HEPES, 20% glycerol and 100 mM KCl at pH = 7.9) with a total volume of 15 microL at 37degreesC for two hours.
###end p 71
###begin title 72
Two-dimensional electrophoresis and protein identification
###end title 72
###begin p 73
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1035 1038 1035 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1147 1150 1147 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 1241 1244 1241 1244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
2D gel electrophoresis was conducted using the IPGphor system (Amersham Biosciences). After the nuclear extracts had incubated with 3Cpro and precipitated using 20% trichloroacetic acid (TCA), the sample was dissolved in 8 M Urea, 2% CHAPS, 0.5% IPG buffer (Amersham Bioscience) and bromophenol blue. These samples were loaded on a cup-loading system (Amersham Biosciences). Isoelectric focusing was performed at 45,000 Vh in a stepwise fashion (1500 V, gradient for 2 hours; 4000 V, gradient for 3500 V.hours; 8000 V, step-on-hold until the end) in Immobiline Drystrip IEF gels with the range of pH 3-10 (Amersham Biosciences). For SDS-PAGE, the IEF gels were loaded on gels with graded acryamide conc. of 9% to 16%. Proteins on 2D electrophoresis gels were visualized by silver staining and the results were scanned as TIF files. Protein spots on scanned gels were analyzed using PDquest v7.0 (Bio-rad) software. Six pairs of gels with a similarity of over 60% were selected for further analysis. Spots that appeared in the mutant 3Cpro-treated nuclear extracts disappeared or became at least 50% smaller upon silver staining of the wild-type 3Cpro-treated nuclear extracts were selected as the potential target substrates for wild-type 3Cpro. Following this selection strategy, proteins that yielded similar results to each other more than three times were identified by in-gel digestion and analyzed by Bruker Ultraflex MALDI-TOF mass spectrometry. Mass lists were performed peptide mass fingerprinting by Biotool 2.0 software and the algorithm of Masscot ().
###end p 73
###begin title 74
Confocal imaging
###end title 74
###begin p 75
###xml 93 107 <span type="species:ncbi:39054">enterovirus 71</span>
###xml 566 570 <span type="species:ncbi:39054">EV71</span>
###xml 663 667 <span type="species:ncbi:39054">EV71</span>
###xml 916 920 <span type="species:ncbi:9925">goat</span>
###xml 926 931 <span type="species:ncbi:10090">mouse</span>
###xml 939 943 <span type="species:ncbi:9925">goat</span>
###xml 949 955 <span type="species:ncbi:9986">rabbit</span>
###xml 981 985 <span type="species:ncbi:9925">goat</span>
###xml 991 994 <span type="species:ncbi:10116">rat</span>
RD cells were seeded onto 22 mm diameter coverslips to 80% confluence and were infected with enterovirus 71 (strain 4643/TW/1998) at a multiplicity of infection of 40. At each time point, the culture medium was removed and the cells were washed with PBS, and fixed with 3.7% formaldehyde for 20 min at room temperature. The cells were then washed with PBS and permeabilized using 0.3% Triton X-100 for 5 min at room temperature. Cells were washed once using PBS containing 2% FBS, incubated in blocking solution for 1 hr at room temperature. In CstF-64, hnRNP K and EV71 2B immunostaining, cells were incubated with anti-CstF-64 (diluted 1:100; Santa Cruz), anti-EV71 2B (diluted 1:200; Provided by Dr. Jim-Tong Horng) for 8 hours at 4degreesC or anti-hnRNP K (diluted 1:200; Santa Cruz) for 1.5 hr at room temperature. After they had been washed three times with PBS, coverslips were incubated with FITC-conjugated goat anti-mouse IgG or goat anti-rabbit lgG, and Alexa Fluor 568 goat anti-rat IgG (Invitrogen) for 1 hr at room temperature. The coverslips were then washed once with PBS; treated with nuclear stain Hoechst 33258 (diluted 1:500) for 15 min; washed three times with PBS, and mounted on glass slides with mounting fluid (75% glycerol in PBS). The images were obtained under a confocal laser-scanning microscope (Zeiss; LSM 510 NLO).
###end p 75
###begin title 76
###xml 39 43 <span type="species:ncbi:39054">EV71</span>
Detection of EGFP pre-mRNA and mRNA in EV71-infected cells
###end title 76
###begin p 77
###xml 269 306 269 306 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCGGAATTCTGAGCAAAGACCCCAACGAG -3&#8242;</named-content>
###xml 311 347 311 347 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCCAAGCTTAAAATATTAACGCTTACAAT-3&#8242;</named-content>
###xml 492 521 492 521 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCGGAATTCTGAGCAAAGACCCCAACGAG</named-content>
###xml 488 525 488 525 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- <named-content content-type="gene">CCGGAATTCTGAGCAAAGACCCCAACGAG</named-content> -3&#8242;</named-content>
###xml 534 554 534 554 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTTTTTTTTTTTTTTGCAGT</named-content>
###xml 530 557 530 557 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- <named-content content-type="gene">TTTTTTTTTTTTTTTGCAGT</named-content>-3&#8242;</named-content>
###xml 685 705 685 705 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ATGGTGAGCAAGGGCGAGGA</named-content>
###xml 682 708 682 708 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-<named-content content-type="gene">ATGGTGAGCAAGGGCGAGGA</named-content>-3&#8242;</named-content>
###xml 716 736 716 736 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTTGTACAGCTCGTCCATGC</named-content>
###xml 713 739 713 739 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-<named-content content-type="gene">CTTGTACAGCTCGTCCATGC</named-content>-3&#8242;</named-content>
###xml 86 90 <span type="species:ncbi:39054">EV71</span>
After they had been transfected with pEGFP-N1 for 1 hour, RD cells were infected with EV71 virus. The total RNA of these infected cells were isolated by TRIZOL Reagent (Invitrogen) and purified by phenol/chloroform extraction. To detect EGFP pre-mRNA, a set of primers 5'- CCGGAATTCTGAGCAAAGACCCCAACGAG -3' and 5'- CCCAAGCTTAAAATATTAACGCTTACAAT-3', which target the sequence that was removed from pre-mRNA following polyadenylation was used. To detect poly(A) EGFP mRNA, a set of primers 5'- CCGGAATTCTGAGCAAAGACCCCAACGAG -3' and 5'- TTTTTTTTTTTTTTTGCAGT-3', which target the poly(A) tail and polyadenylation site of EGFP mRNA, were used. To detect total EGFP RNA, a set of primers 5'-ATGGTGAGCAAGGGCGAGGA-3' and 5'-CTTGTACAGCTCGTCCATGC-3', which target the coding region of EGFP was used. The RT-PCR products were placed in 2% agarose gel with ethidium bromide, and semi-quantified using software FUJIFILM Science Lab 2005 (Fuji).
###end p 77
###begin title 78
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro 3'-end pre-mRNA processing and polyadenylation assay
###end title 78
###begin p 79
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dra</italic>
###xml 213 221 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 350 358 350 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 50 54 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Capped RNA substrate with a poly(A) signal of the SV40 late gene was synthesized using a Megascript SP6 kit (Ambion) and Cap analog (Ambion). Plasmid pG3SVL-6, flanked by DraI, was utilized as the template in the in vitro transcription reaction. The synthesized capped RNA substrate was purified by phenol/chloroform extraction before it was used in in vitro 3'-end pre-mRNA processing and polyadenylation assay.
###end p 79
###begin p 80
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 182 185 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 499 507 485 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 623 624 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 686 689 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
The nuclear extract was treated with recombinant 3Cpro at 37degreesC for two hours before it was used in 3' pre-mRNA processing and polyadenylation assay. After the treatment, the 3Cpro activity was stopped by adding protease inhibit cocktail (Roche). The volume of each 3' pre-mRNA processing reaction with 20 microl contained 25% (v/v) nuclear extract (25 microg in total), and 2 ng of RNA subtrates with added 1 mM EDTA, 0.5 mM dATP, 10 mM creatine phosphate, 2.5% (v/v) of polyvinyl alcohol. In in vitro polyadenylation, dATP was replaced by ATP, and the conc. of EDTA declined to 0.08 mM with the addition of 1 mM MgCl2. 4 microg of recombinant CstF-64 was added into one of the 3Cpro-treated reaction. After incubation for two hours at 37degreesC, the assayed RNA was purified phenol/chloroform extraction. The purified RNA was analyzed in 1.5% agarose gel and denatured using formaldehyde.
###end p 80
###begin title 81
Real-time RT-PCR
###end title 81
###begin p 82
###xml 308 336 308 336 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGAGAGCTCCCAGATGACTGA-3&#8242;</named-content>
###xml 670 694 670 694 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGGGATCAGGGCAGCAA-3&#8242;</named-content>
###xml 699 729 699 729 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGGGTCTGGGAGTTCTAGATGTG-3&#8242;</named-content>
Real-time RT-PCR was performed to detect levels of IL-10RB RNA. The High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was applied for reverse transcription. To differentiate pre-mRNA and polyadenylated IL-10RB RNA, different primers were used in reverse transcription step. A specific primer 5'-CTGAGAGCTCCCAGATGACTGA-3' that targets the region that contains polyadenylation cleavage signal on IL-10RB was used to detect the pre-mRNA. On the other hand, an oligo-d(T) was used as the primer to detect poly(A)-mRNA. For total mRNA (including pre-mRNA and poly(A)-mRNA), a random hexomer was used an the primer in reverse transcription step. For PCR step, 5'-GAGGGATCAGGGCAGCAA-3' and 5'-CAGGGTCTGGGAGTTCTAGATGTG-3' designed by Primer Express software (Applied Biosystems) targeting IL-10RB coding region were used. The PCR reaction was performed on 7500 Real-Time PCR System (Applied Biosystem) using SYBR Green Core Kit (Applied Biosystem).
###end p 82
###begin title 83
Supporting Information
###end title 83
###begin p 84
###xml 11 15 <span type="species:ncbi:39054">EV71</span>
###xml 80 84 <span type="species:ncbi:39054">EV71</span>
###xml 180 184 <span type="species:ncbi:39054">EV71</span>
CstF-64 in EV71-infected cell of m.o.i. of 1. After RD cells were infected with EV71 (m.o.i. = 1) and CstF-64 protein in total cellular protein of mock infected RD cells (Mock) or EV71-infected cells at various hours post-infection (h.p.i) were detected. The cleavage product of 55 kDa is also denoted (*).
###end p 84
###begin p 85
(2.78 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 27 31 <span type="species:ncbi:39054">EV71</span>
###xml 80 84 <span type="species:ncbi:39054">EV71</span>
The location of hnRNP K in EV71-infected cells. HnRNP K in uninfected (Mock) or EV71-infected cells at 2, 4, 6, 8 and 10 h.p.i. were detected using specific antibody. The detection of viral 2B protein was applied as an infection-positive marker. The nuclei of cells were stained using Hoechst dye.
###end p 87
###begin p 88
(1.47 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 211 214 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
CstF-64 cleaved by various amounts of recombinant 3Cpro. [35S]-labeled CstF-64 proteins were treated with catalytic mutant 3C (C147S) or various amounts (0.1, 0.2, 0.5, 1.0, 1.5, 2.0, 5.0 microg) of wild-type 3Cpro (WT). The full-length CstF-64 (CstF-64) and the cleavage products of 55 kDa (p55), 35 kDa (p35), 30 kDa (p30) and 25 kDa (p25) are denoted.
###end p 90
###begin p 91
(1.78 MB TIF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
The 3Cpro cleavage of CstF-64 with mutantion at Gln251 or position 500. [35S]-labeled wild-type CstF-64 (WT) or mutant CstF-64 at Gln251 (Q251A) or position 500 (Q483A Q496A Q505A Q510A Q515A) were untreated (-) or treated with wild-type 3Cpro (WT) and mutant 3C protein (C147S). The full-length of CstF-64 (CstF-64) and cleavage products of 55 kDa (p55), 35 kDa (p35), 30 kDa (p30) and 25 kDa (p25) are denoted.
###end p 93
###begin p 94
(2.73 MB TIF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</sup>
###xml 34 38 <span type="species:ncbi:39054">EV71</span>
###xml 120 124 <span type="species:ncbi:39054">EV71</span>
CstF-64 and poly(A) polymerase in EV71-infected cells. CstF-64, poly(A) polymerase and 3Cpro in mock-infected (Mock) or EV71-infected cells at 6 and 8 hours post-infection (6 and 8 h.p.i.) were detected. The cleavage product of 55 kDa from CstF-64 is denoted as *. The beta-actin was used as a loading control.
###end p 96
###begin p 97
(3.90 MB TIF)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
The authors would like to thank Dr. James L. Manely and Dr. Yoshio Takagaki for providing pZ64-18 and pG3SVL-A plasmid, respectively. We would also like to thank Dr. Clinton C. MacDonald for providing monoclonal anti-CstF-64 antibody. We would also like to thank Dr. Jim-Tong Horng for providing 2B antibody and the Proteomic Center of Chang Gung University, especially Dr. Jau-Song Yu and Dr. Kun-Yi Chien for their technical support. Ted Knoy is appreciated for his editorial assistance.
###end p 99
###begin title 100
References
###end title 100
###begin article-title 101
###xml 15 29 <span type="species:ncbi:39054">enterovirus 71</span>
An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.
###end article-title 101
###begin article-title 102
###xml 64 72 <span type="species:ncbi:9606">children</span>
[Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen].
###end article-title 102
###begin article-title 103
###xml 18 32 <span type="species:ncbi:39054">enterovirus 71</span>
Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia.
###end article-title 103
###begin article-title 104
###xml 25 39 <span type="species:ncbi:39054">enterovirus 71</span>
Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia.
###end article-title 104
###begin article-title 105
###xml 31 45 <span type="species:ncbi:39054">enterovirus 71</span>
###xml 59 67 <span type="species:ncbi:9606">children</span>
Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia.
###end article-title 105
###begin article-title 106
###xml 32 46 <span type="species:ncbi:39054">enterovirus 71</span>
An overview of the evolution of enterovirus 71 and its clinical and public health significance.
###end article-title 106
###begin article-title 107
###xml 12 26 <span type="species:ncbi:39054">enterovirus 71</span>
Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement.
###end article-title 107
###begin article-title 108
###xml 0 14 <span type="species:ncbi:39054">Enterovirus 71</span>
Enterovirus 71 infections and neurologic disease-United States, 1977-1991.
###end article-title 108
###begin article-title 109
###xml 33 47 <span type="species:ncbi:39054">Enterovirus 71</span>
Molecular characterization of an Enterovirus 71 causing neurological disease in Germany.
###end article-title 109
###begin article-title 110
###xml 0 14 <span type="species:ncbi:39054">Enterovirus 71</span>
Enterovirus 71 outbreak, Brunei.
###end article-title 110
###begin article-title 111
###xml 52 62 <span type="species:ncbi:138953">poliovirus</span>
Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.
###end article-title 111
###begin article-title 112
###xml 29 39 <span type="species:ncbi:138953">poliovirus</span>
Inhibition of translation by poliovirus: inactivation of a specific initiation factor.
###end article-title 112
###begin article-title 113
###xml 0 10 <span type="species:ncbi:138953">Poliovirus</span>
###xml 171 181 <span type="species:ncbi:138953">poliovirus</span>
Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus.
###end article-title 113
###begin article-title 114
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 49 59 <span type="species:ncbi:138953">poliovirus</span>
Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro.
###end article-title 114
###begin article-title 115
###xml 61 71 <span type="species:ncbi:138953">poliovirus</span>
Site-directed mutagenesis of the putative catalytic triad of poliovirus 3C proteinase.
###end article-title 115
###begin article-title 116
###xml 49 59 <span type="species:ncbi:138953">poliovirus</span>
Analysis of putative active site residues of the poliovirus 3C protease.
###end article-title 116
###begin article-title 117
###xml 13 29 <span type="species:ncbi:169066">human rhinovirus</span>
Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein.
###end article-title 117
###begin article-title 118
###xml 48 58 <span type="species:ncbi:138953">poliovirus</span>
Refined X-ray crystallographic structure of the poliovirus 3C gene product.
###end article-title 118
###begin article-title 119
###xml 38 52 <span type="species:ncbi:39054">enterovirus 71</span>
Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities.
###end article-title 119
###begin article-title 120
###xml 28 42 <span type="species:ncbi:39054">enterovirus 71</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
The 3C protease activity of enterovirus 71 induces human neural cell apoptosis.
###end article-title 120
###begin article-title 121
###xml 67 77 <span type="species:ncbi:138953">poliovirus</span>
Primary structure, gene organization and polypeptide expression of poliovirus RNA.
###end article-title 121
###begin article-title 122
Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells.
###end article-title 122
###begin article-title 123
###xml 17 27 <span type="species:ncbi:138953">poliovirus</span>
Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off.
###end article-title 123
###begin article-title 124
###xml 41 51 <span type="species:ncbi:138953">poliovirus</span>
###xml 94 104 <span type="species:ncbi:138953">poliovirus</span>
Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro.
###end article-title 124
###begin article-title 125
###xml 47 57 <span type="species:ncbi:138953">poliovirus</span>
Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro.
###end article-title 125
###begin article-title 126
###xml 0 28 <span type="species:ncbi:12110">Foot-and-mouth disease virus</span>
Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3.
###end article-title 126
###begin article-title 127
###xml 0 10 <span type="species:ncbi:138953">Poliovirus</span>
Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity.
###end article-title 127
###begin article-title 128
The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability system.
###end article-title 128
###begin article-title 129
Role of polyadenylation in nucleocytoplasmic transport of mRNA.
###end article-title 129
###begin article-title 130
Starting at the beginning, middle, and end: translation initiation in eukaryotes.
###end article-title 130
###begin article-title 131
Life and death in the cytoplasm: messages from the 3' end.
###end article-title 131
###begin article-title 132
###xml 21 31 <span type="species:ncbi:138953">poliovirus</span>
Relationship between poliovirus negative-strand RNA synthesis and the length of the 3' poly(A) tail.
###end article-title 132
###begin article-title 133
###xml 38 55 <span type="species:ncbi:12092">hepatitis A virus</span>
Replication and in vivo repair of the hepatitis A virus genome lacking the poly(A) tail.
###end article-title 133
###begin article-title 134
###xml 91 101 <span type="species:ncbi:138953">poliovirus</span>
Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded.
###end article-title 134
###begin article-title 135
Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.
###end article-title 135
###begin article-title 136
Mechanism and regulation of mRNA polyadenylation.
###end article-title 136
###begin article-title 137
The 64-kilodalton subunit of the CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage site and influences cleavage site location.
###end article-title 137
###begin article-title 138
A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs.
###end article-title 138
###begin article-title 139
Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences.
###end article-title 139
###begin article-title 140
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 106 109 <span type="species:ncbi:10116">rat</span>
Developmental distribution of the polyadenylation protein CstF-64 and the variant tauCstF-64 in mouse and rat testis.
###end article-title 140
###begin article-title 141
###xml 11 21 <span type="species:ncbi:138953">poliovirus</span>
Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition.
###end article-title 141
###begin article-title 142
Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus.
###end article-title 142
###begin article-title 143
###xml 63 77 <span type="species:ncbi:39054">enterovirus 71</span>
Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication.
###end article-title 143
###begin article-title 144
###xml 54 64 <span type="species:ncbi:138953">poliovirus</span>
The presence of viral-induced proteins in nuclei from poliovirus-infected HeLa cells.
###end article-title 144
###begin article-title 145
###xml 57 71 <span type="species:ncbi:39054">enterovirus 71</span>
Identification of genes involved in the host response to enterovirus 71 infection.
###end article-title 145
###begin article-title 146
###xml 54 68 <span type="species:ncbi:39054">enterovirus 71</span>
Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation.
###end article-title 146
###begin article-title 147
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifs.
###end article-title 147
###begin article-title 148
###xml 62 67 <span type="species:ncbi:9606">human</span>
Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein.
###end article-title 148
###begin article-title 149
###xml 40 45 <span type="species:ncbi:9606">human</span>
Complex protein interactions within the human polyadenylation machinery identify a novel component.
###end article-title 149
###begin article-title 150
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
The Drosophila homologue of the 64 kDa subunit of cleavage stimulation factor interacts with the 77 kDa subunit encoded by the suppressor of forked gene.
###end article-title 150
###begin article-title 151
Evolutionarily conserved interaction between CstF-64 and PC4 links transcription, polyadenylation, and termination.
###end article-title 151
###begin article-title 152
###xml 53 58 <span type="species:ncbi:4932">yeast</span>
The C-terminal domains of vertebrate CstF-64 and its yeast orthologue Rna15 form a new structure critical for mRNA 3'-end processing.
###end article-title 152
###begin article-title 153
Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.
###end article-title 153
###begin article-title 154
###xml 37 54 <span type="species:ncbi:11320">influenza A virus</span>
Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.
###end article-title 154
###begin article-title 155
The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells.
###end article-title 155
###begin article-title 156
###xml 108 118 <span type="species:ncbi:138953">poliovirus</span>
Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited.
###end article-title 156
###begin article-title 157
Internal initiation of translation mediated by the 5' leader of a cellular mRNA.
###end article-title 157
###begin article-title 158
Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites.
###end article-title 158
###begin p 159
The authors have declared that no competing interests exist.
###end p 159
###begin p 160
This study was supported by the National Science Council of the Republic of China, Taiwan, under Contract No. NSC 97-2320-B-182-007-MY3 (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 160

